Instant International
Written by: He Wenhan
2021-06-13 02:04
Last update date: 2021-06-13 02:04
On June 11, the European Medicines Agency (EMA) confirmed that another rare blood disease, Capillary Leak Syndrome (CLS), is a potential side effect of vaccination "AstraZeneca".
"AstraZeneca Vaccine" is a novel coronavirus pneumonia (COVID-19) vaccine jointly developed by the British pharmaceutical company AstraZeneca and the University of Oxford.
The Safety Committee of the European Medicines Agency said that the new side effect of CLS must be added to the vaccine label.
New crown pneumonia outbreak in the United Kingdom: The picture shows a woman vaccinated against the new crown pneumonia at a vaccine center in Hexham on May 13, England.
(Getty)
The European Medicines Agency pointed out that this disease is fluid leakage from the smallest blood vessels, which can cause swelling and a drop in blood pressure. People who have experienced this should not receive injections.
The safety committee has reviewed 6 confirmed cases of CLS, most of which are women, and one of them died.
They have all been vaccinated with the "AstraZeneca vaccine."
Three of the six patients had a history of CLS.
China CanSino Vaccines Grants Emergency Use Authorization in Argentina
New crown pneumonia | US media: Johnson & Johnson 60 million doses of vaccine are contaminated, US orders destruction
Hundreds of people in the U.S. develop myocarditis or pericarditis after being vaccinated with the new crown vaccine. Experts will meet to discuss
In its statement, AstraZeneca pointed out that CLS cases are extremely rare, with less than 1 out of 10 million vaccinated persons having CLS status.
Covid-19 vaccine vaccine AstraZeneca vaccine Covid-19 vaccine side effects Covid-19 pneumonia